Sökresultat - Роберто Пили
- Visas 1 - 20 av 79 resultat
- Gå till nästa sida
-
1
-
2
-
3
Targeting tumor angiogenesis with histone deacetylase inhibitors av Leigh Ellis, Hans J. Hammers, Роберто Пили
Publicerad 2008Revisão -
4
-
5
-
6
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor... av Sreenivasulu Chintala, Tanbir Najrana, Károly Tóth, Shousong Cao, Farukh A. Durrani, Роберто Пили, Youcef M. Rustum
Publicerad 2012Artigo -
7
-
8
-
9
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic... av Daniel Keizman, Maya Ish‐Shalom, Peng Huang, Mario A. Eisenberger, Роберто Пили, Hans J. Hammers, Michael A. Carducci
Publicerad 2011Artigo -
10
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours av Роберто Пили, Brenda Salumbides, Ming Zhao, Soner Altiok, David Z. Qian, James A. Zwiebel, Michael A. Carducci, Michelle A. Rudek
Publicerad 2011Artigo -
11
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination av Daniel Keizman, Peng Huang, Mario A. Eisenberger, Роберто Пили, Jenny J. Kim, Emmanuel S. Antonarakis, Hans J. Hammers, Michael A. Carducci
Publicerad 2011Artigo -
12
-
13
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells av Rosalba Minelli, Roberta Cavalli, Leigh Ellis, Piergiorgio Pettazzoni, Francesco Trotta, Eric Ciamporcero, Giuseppina Barrera, Roberto Fantozzi, Chiara Dianzani, Роберто Пили
Publicerad 2012Artigo -
14
Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model av Dudley W. Lamming, Nicole E. Cummings, Antonella Rastelli, Feng Gao, Edda Cava, Beatrice Bertozzi, Francesco Spelta, Роберто Пили, Luigi Fontana
Publicerad 2015Artigo -
15
Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models av Li Shen, Michael J. Ciesielski, Swathi Ramakrishnan, Kiersten Marie Miles, Leigh Ellis, Paula Sotomayor, Protul Shrikant, Robert A. Fenstermaker, Роберто Пили
Publicerad 2012Artigo -
16
Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors av Henk M.W. Verheul, Brenda Salumbides, Karen van Erp, Hans J. Hammers, David Z. Qian, Tolib B. Sanni, Peter Atadja, Роберто Пили
Publicerad 2008Artigo -
17
Antitumor effect of the histone deacetylase inhibitor LAQ824 in combination with 13-<i>cis</i>-retinoic acid in human malignant melanoma av Yukihiko Kato, Brenda Salumbides, Xiao-Fei Wang, David Z. Qian, Simon A. Williams, Yongfeng Wei, Tolib B. Sanni, Peter Atadja, Роберто Пили
Publicerad 2007Artigo -
18
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer av Eric Ciamporcero, Martina Daga, Stefania Pizzimenti, Antonella Roetto, Chiara Dianzani, Alessandra Compagnone, A Palmieri, Chiara Ullio, Luigi Cangemi, Роберто Пили, Giuseppina Barrera
Publicerad 2017Artigo -
19
Data-Independent Acquisition Phosphoproteomics of Urinary Extracellular Vesicles Enables Renal Cell Carcinoma Grade Differentiation av Marco Hadisurya, Zheng-Chi Lee, Zhuojun Luo, Guiyuan Zhang, Yajie Ding, Hao Zhang, Anton Iliuk, Роберто Пили, Ronald S. Boris, W. Andy Tao
Publicerad 2023Artigo -
20
Dietary protein restriction inhibits tumor growth in human xenograft models of prostate and breast cancer av Luigi Fontana, Remi Adelaiye‐Ogala, Antonella Rastelli, Kiersten Marie Miles, Eric Ciamporcero, Valter D. Longo, Holly M. Nguyen, Robert L. Vessella, Роберто Пили
Publicerad 2013Artigo
Sökverktyg:
Relaterade ämnen
Medicine
Internal medicine
Cancer
Oncology
Cancer research
Biology
Biochemistry
Gene
Renal cell carcinoma
Prostate cancer
Sunitinib
Chemistry
Genetics
Pharmacology
Pathology
Histone
Histone deacetylase
Angiogenesis
Cell biology
Gastroenterology
Adverse effect
Chemotherapy
Urology
Apoptosis
Progression-free survival
Clinical endpoint
Clinical trial
Immunology
Immune system
In vitro